Literature DB >> 11359161

Facial nerve monitoring in middle ear and mastoid surgery.

R S Noss1, A K Lalwani, C D Yingling.   

Abstract

HYPOTHESIS: Intraoperative electromyographic facial nerve monitoring, long accepted as the standard of care in surgery for acoustic neuroma and other cerebellopontine angle tumors, may be of aid in middle ear and mastoid surgery. STUDY
DESIGN: Retrospective series of 262 cases of middle ear/mastoid surgery in which monitoring was performed by a neurophysiologist.
METHODS: Neurophysiological monitoring events were classified as mechanical or electrical. The voltages producing facial nerve stimulation were compiled and compared with observed facial nerve dehiscence.
RESULTS: The most common use of monitoring was localization of the facial nerve by electrical stimulation (60%) or identification of mechanically evoked activity (39%). In 57 cases (36%), the first electrical stimulation event evoked a facial nerve response at less than 1 V threshold, indicating little or no bony covering. The minimum stimulation threshold throughout each of these cases was less than 1 V in 88 of the 159 cases (55%) in which stimulation was attempted. In contrast, the facial nerve was visibly dehiscent in only 35 cases (13%). Neurophysiological monitoring confirmed aberrant facial nerve course through the temporal bone in four cases resulting in cancellation of surgical treatment in two cases. Postoperative facial nerve function was preserved in all cases when present preoperatively.
CONCLUSIONS: An electrical stimulation threshold of less than 1 V is a more useful criterion of dehiscence than observation under the operating microscope. The absence of monitoring events allows safe dissection. Monitoring can help locate the facial nerve, guide the dissection and drilling, and confirm its integrity, thereby allowing more definitive surgical treatment while preserving neural function.

Entities:  

Mesh:

Year:  2001        PMID: 11359161     DOI: 10.1097/00005537-200105000-00014

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  [Diagnostics of diseases and the function of the facial nerve].

Authors:  O Guntinas-Lichius; C Sittel
Journal:  HNO       Date:  2004-12       Impact factor: 1.284

Review 2.  [Principles of cholesteatoma surgery].

Authors:  T Stark; A Gurr; H Sudhoff
Journal:  HNO       Date:  2011-04       Impact factor: 1.284

3.  Warning navigation system using real-time safe region monitoring for otologic surgery.

Authors:  Byunghyun Cho; Masamichi Oka; Nozomu Matsumoto; Riichi Ouchida; Jaesung Hong; Makoto Hashizume
Journal:  Int J Comput Assist Radiol Surg       Date:  2012-11-16       Impact factor: 2.924

4.  Facial canal dehiscence in patients with cholesteatoma: concordance between intraoperative inspection, computed tomography and neurophysiological findings.

Authors:  Francisco Arias-Marzán; Gemma de Lucas-Carmona; Esteban Reinaldo Pacheco Coronel; Pedro Javier Perez Lorensu; Alejandro Jiménez-Sosa; Blas Pérez-Piñero
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-04-06       Impact factor: 2.503

5.  Facial nerve outcome after vestibular schwannoma surgery: our experience.

Authors:  Vittorio Rinaldi; Manuele Casale; Federica Bressi; Massimiliano Potena; Emanuela Vesperini; Antonio De Franco; Sergio Silvestri; Carlo Zini; Fabrizio Salvinelli
Journal:  J Neurol Surg B Skull Base       Date:  2012-02

6.  Contemporary Opinions on Intraoperative Facial Nerve Monitoring.

Authors:  Paul W Gidley; Jennifer Maw; Bruce Gantz; David Kaylie; Paul Lambert; Sonya Malekzadeh; Sujana S Chandrasekhar
Journal:  OTO Open       Date:  2018-08-07

7.  The optimal and safe intensity for facial nerve stimulation during intraoperative neuromonitoring in middle ear surgery.

Authors:  Euyhyun Park; Hyunjung Kim; Hye Min Han; In Hak Choi; Hak Hyun Jung; Gi Jung Im
Journal:  PLoS One       Date:  2019-08-29       Impact factor: 3.240

Review 8.  Midline Facial Nerve Monitoring: Single-Center Experience and Review of Literature.

Authors:  Mohammed A Jomah; Eman A Hajr
Journal:  J Int Adv Otol       Date:  2022-01       Impact factor: 1.316

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.